{"id":"W1984633162","doi":"10.1016/j.rhum.2007.10.073","title":"Tumeurs malignes (TM) dans le programme de développement clinique (PDC) de l'abatacept dans la polyarthrite rhumatoïde (PR) : données épidémiologiques actualisées","year":2007,"lang":"fr","type":"article","venue":"Revue du Rhumatisme","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Arthritis Research Centre of Canada; University of British Columbia; McGill University","funders":"","keywords":"Medicine; Tofacitinib; Abatacept; Tocilizumab; Rheumatoid arthritis; Rituximab; Azathioprine; Internal medicine; Rheumatism; Methotrexate; Adverse effect; Surgery; Disease; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008670745,0.0009628012,0.001458042,0.0004741717,0.000987974,0.0004344601,0.0008767321,0.0008624937,0.0006001376],"category_scores_gemma":[0.001991352,0.0009752553,0.0005830423,0.0005272885,0.002129063,0.0006591842,0.0003512124,0.00125493,0.0002121088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001102976,"about_ca_system_score_gemma":0.001541576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001718526,"about_ca_topic_score_gemma":0.00301028,"domain_scores_codex":[0.9906497,0.002009324,0.001857969,0.001046067,0.000726347,0.003710614],"domain_scores_gemma":[0.994644,0.001845445,0.0005641071,0.001067571,0.0003136052,0.001565261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0008105665,0.002784278,0.3158269,0.002734008,0.001194818,0.005998049,0.1323585,0.00003659193,0.02289623,0.1950792,0.005070359,0.3152105],"study_design_scores_gemma":[0.01248101,0.005690876,0.4885089,0.02247055,0.0002024425,0.01496609,0.06508533,0.001643607,0.07165843,0.03328496,0.2804456,0.003562119],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8645043,0.07367615,0.03438263,0.01790926,0.0008184215,0.001903908,0.0001546455,0.000600469,0.006050186],"genre_scores_gemma":[0.8218036,0.1520434,0.02110747,0.0005120034,0.001106153,0.0003107169,0.0001604927,0.0002146492,0.002741501],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3116483,"threshold_uncertainty_score":0.9992698,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02765268191739555,"score_gpt":0.308830392067635,"score_spread":0.2811777101502395,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}